IL17A and systemic sclerosis: While increased number of Th17 cells or elevated levels of IL-17A have been reported by many investigators in the peripheral blood [12], [13], bronchoalveolar lavage fluid [14] and the dermis of SSc individuals [15], the available data in humans do not unanimously point to a clear pro-fibrotic role of IL-17A (reviewed in [16]).